The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder

Family Practice

Volumn 24, Issue 6, 2007, Pages 538-546

  Smolders, Mirrian ^a   Laurant, Miranda ^a   Van rijswijk, Eric ^a   Mulder, Jan ^a   Braspenning, Jozé ^a   Verhaak, Peter ^b   Wensing, Michel ^a   Grol, Richard ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Cohort study; Family medicine; Patient record; Prescribing; Psychiatry

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA EXTRACTION; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MENTAL DISEASE; NETHERLANDS; PRACTICE GUIDELINE; PRESCRIPTION; SOCIAL PROBLEM;

ADULT; ANXIETY DISORDERS; COHORT STUDIES; COMORBIDITY; DECISION MAKING; FEMALE; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG;

EID: 37749012238     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmm062     Document Type: Article

References (35)

1. Bakish D. The patient with comorbid depression and anxiety: The unmet need. J Clin Psychiatry 1999; 60 (Suppl 6): 20-24.
2. Sareen J, Cox BJ, Clara I, Asmundson GJ. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress Anxiety 2005; 24 (6): 538-546.
3. de Graaf R, Bijl RV, Spijker J, Beekman AT, Vollebergh WA. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders-findings from the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol 2003; 38 (1): 1-11.
4. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996; (30): 17-30.
5. Merikangas KR, Angst J, Eaton W et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl 1996; (30): 58-67.
6. Verhaak PF, Schellevis FG, Nuijen J, Volkers AC. Patients with a psychiatric disorder in general practice: Determinants of general practitioners' psychological diagnosis. Gen Hosp Psychiatry 2006; 28 (2): 125-132.
7. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994; 272 (22): 1741-1748.
8. Rodriguez BF, Bruce SE, Pagano ME, Keller MB. Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord 2005; 19 (7): 752-766.
9. Meijer WE, Heerdink ER, Leufkens FG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004; 60 (1): 57-61.
10. Willison DJ, Kirshen AJ, Anderson G. Long-term use of benzodiazepines among community dwelling seniors in Ontario - area variation and patient-level predictors. Pharmacoepidemiol Drug Saf 1998; 7 (Suppl 2):147.
11. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain 2003; 106 (1-2): 127-133.
12. Bijl RV, Ravelli A. Psychiatric morbidity, service use, and need for care in the general population: Results of The Netherlands Mental Health Survey and Incidence Study. Am J Public Health 2000; 90 (4): 602-607.
13. Hecht H, von Zerssen D, Wittchen HU. Anxiety and depression in a community sample: The influence of comorbidity on social functioning. J Affect Disord 1990; 18 (2): 137-144.
14. Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med 1997; 27 (4): 861-873.
15. Roy Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000; 176: 229-235.
16. Wittchen HU, Lieb R, Wunderlich U, Schuster P. Comorbidity in primary care: Presentation and consequences. J Clin Psychiatry 1999; 60 (Suppl 7): 29-36.
17. Coulehan JL, Schulberg HC, Block MR, Janosky JE, Arena VC. Medical comorbidity of major depressive disorder in a primary medical practice. Arch Intern Med 1990; 150 (11): 2363-2367.
18. Freeling P, Rao BM, Paykel ES, Sireling LI, Burton RH. Unrecognised depression in general practice. Br Med J (Clin Res Ed) 1985; 290: 1880-1883.
19. Tylee A, Freeling P, Kerry S, Burns T. How does the content of consultations affect the recognition by general practitioners of major depression in women? Br J Gen Pract 1995; 45: 575-578.
20. Pini S, Berardi D, Rucci P et al. Identification of psychiatric distress by primary care physicians. Gen Hosp Psychiatry 1997; 19: 411-418.
21. Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: Results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996; (30): 38-43.
22. Cunningham LA. Depression in the medically ill: Choosing an antidepressant. J Clin Psychiatry 1994; 55 (Suppl A): 90-97.
23. van Rijswijk E, Borghuis M, van De Lisdonk E, Zitman F, van Weel C. Treatment of mental health problems in general practice: A survey of psychotropics prescribed and other treatments provided. Int J Clin Pharmacol Ther 2007; 45: 23-29.
24. van Rijswijk E, Lucassen P, van De Lisdonk E, Zitman F, van Weel C. Do co-existing psychosocial problems influence the prescription of psychotropic medication in depressive and anxiety disorders? Eur J Gen Pract 2006; 12 (1): 37-39.
25. Smolders M, Laurant M, van Rijswijk E et al. Depressed and a comorbid condition: More psychotropics prescribed! Submitted.
26. Verheij R, Jabaaij L, De Bakker D et al. Cijfers nit bet Landelijk Informatie Netwerk Huisartsenzorg: Contacten, verwijzingen en voorschrijven in de huisartspraktijk (LINH Year-Report 2001; Figures from the Dutch Continuous Morbidity Registration Network in General Practice: Encounters, Referrals, and Prescriptions in General Practice. 2002; Utrecht, Nijmegen: LHV, NHG, NIVEL, WOK.
27. Lamberts H, Wood M. International Classification of Primary Care (ICPC). Oxford: Oxford University Press, 1990.
28. WHO. Collaborating Centre for Drugs Statistics Methodology Guidelines ATC Classification and DDD Assignment, 1st edn. Oslo: WHO/NCM, 1996.
29. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-411.
30. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: Results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587-595.
31. Merikangas KR, Angst J, Eaton W et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl 1996; (30): 58-67.
32. Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: V. Treatment strategies in panic disorder, 1992-1997. J Clin Psychopharmacol 1998; 18 (6): (Suppl 2): 27S-31S.
33. Terluin B, van Heest FB, van der Meer K et al. Guideline anxiety disorders Dutch College of General Practitioners (first revision). Huisarts Wet 2004; 47 (1): 26-37.
34. Furukawa TA, Streiner DL, Young LT. Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev 2001; (2): CD001026.
35. van Marwijk HW, Grundmeijer HGLM, Brueren MM et al. Guideline depression Dutch college of general practitioners. Huisarts Wet 2000; 37: 482-490.